LJUBLJANA, Feb 27 (Reuters) - Slovenian generic drugs producer Krka KRKG.LJ KRK.WA posted an 8 percent rise in 2013 group net profit to 172.8 million euros on Thursday. In a bourse statement Krka said sales rose by 5 percent to 1.2 billion euros and it expected sales to reach 1.25 billion this year. Shares in Krka, Slovenia's largest listed company and one of its biggest exporters, were quoted at 60.39 euros by 1105 GMT, up 0.65 percent from Wednesday's close. (Reporting by Igor Ilic in Zagreb; editing by Jason Neely) ((igor.ilic@thomsonreuters.com)(+385 1 4899 970)(mobile +385 98 334 053)) Keywords: KRKA/